scPharmaceuticals Inc. (SCPH)
After hours:
- GlobeNewswire
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
BURLINGTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will present at the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11 at 10:00AM ET. Mr. Tucker will als
- Simply Wall St.
After losing 35% in the past year, scPharmaceuticals Inc. (NASDAQ:SCPH) institutional owners must be relieved by the recent gain
Key Insights Significantly high institutional ownership implies scPharmaceuticals' stock price is sensitive to their...
- Zacks
Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect?
The mean of analysts' price targets for scPharmaceuticals (SCPH) points to a 291.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
